| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yushiro Endo, Tomohiro Koga, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana, Yuji Hosono, Tsuneyo Mimori, Atsushi Kawakam. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report. Medicine. vol 97. issue 26. 2018-07-09. PMID:29952940. |
among all dermatomyositis (dm) patients, antimelanoma differentiation-associated gene 5 antibody (anti-mda5 ab) positive patients have significantly poor short-term mortality, whereas they experience less relapses over the long term after the remission. |
2018-07-09 |
2023-08-13 |
Not clear |
| Youhei Fujiki, Takuya Kotani, Kentaro Isoda, Takaaki Ishida, Takeshi Shoda, Shuzo Yoshida, Tohru Takeuchi, Shigeki Makin. Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Modern rheumatology. vol 28. issue 1. 2018-07-05. PMID:28490218. |
we retrospectively investigated clinical prognostic factors for interstitial pneumonia (ip) in anti-melanoma differentiation-associated gene 5 (mda5) antibody (ab)-positive dermatomyositis (dm) patients. |
2018-07-05 |
2023-08-13 |
Not clear |
| Yushiro Endo, Tomohiro Koga, Takahisa Suzuki, Kazusato Hara, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana, Atsushi Kawakam. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report. Medicine. vol 97. issue 15. 2018-04-20. PMID:29642214. |
as the initial treatment of rapidly progressive interstitial lung disease (rpild) with antimelanoma differentiation-associated gene 5 antibody (anti-mda5 ab)-positive dermatomyositis (dm) patients, a combination of corticosteroids, cyclophosphamide, and calcineurin inhibitor is recommended. |
2018-04-20 |
2023-08-13 |
Not clear |
| Yoshiro Horai, Tomohiro Koga, Keita Fujikawa, Ayuko Takatani, Ayako Nishino, Yoshikazu Nakashima, Takahisa Suzuki, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Hiroaki Ida, Tomoyuki Kakugawa, Noriho Sakamoto, Yuji Ishimatsu, Hiroshi Mukae, Yasuhito Hamaguchi, Manabu Fujimoto, Masataka Kuwana, Tomoki Origuchi, Shigeru Kohno, Atsushi Kawakam. Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Modern rheumatology. vol 25. issue 1. 2015-08-21. PMID:24716595. |
we have tried to clarify the clinical importance of the measurement of serum type-i interferon (ifn) in patients with anti-melanoma differentiation-associated gene 5 ab (mda5 ab)-positive dermatomyositis (dm). |
2015-08-21 |
2023-08-13 |
Not clear |
| Kotaro Ito, Shinichi Imafuku, Yasuhito Hamaguchi, Manabu Fujimoto, Juichiro Nakayam. Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. The Journal of dermatology. vol 40. issue 7. 2014-04-24. PMID:23663102. |
anti-transcription intermediary factor-1-γ/α (tif-1-γ/α) ab was recently identified as an auto-ab and was observed mostly in cancer-associated dermatomyositis. |
2014-04-24 |
2023-08-12 |
Not clear |
| Kotaro Ito, Shinichi Imafuku, Yasuhito Hamaguchi, Manabu Fujimoto, Juichiro Nakayam. Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. The Journal of dermatology. vol 40. issue 7. 2014-04-24. PMID:23663102. |
serologically, various auto-antibodies (ab) are associated with dermatomyositis. |
2014-04-24 |
2023-08-12 |
Not clear |
| Yuki Ichimura, Takashi Matsushita, Yasuhito Hamaguchi, Kenzo Kaji, Minoru Hasegawa, Yoshinori Tanino, Yayoi Inokoshi, Kazuhiro Kawai, Takuro Kanekura, Maria Habuchi, Atsuyuki Igarashi, Ryosuke Sogame, Takashi Hashimoto, Tomohiro Koga, Ayako Nishino, Naoko Ishiguro, Naoki Sugimoto, Rui Aoki, Noriko Ando, Tetsuya Abe, Takashi Kanda, Masataka Kuwana, Kazuhiko Takehara, Manabu Fujimot. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Annals of the rheumatic diseases. vol 71. issue 5. 2012-05-31. PMID:22258483. |
recent studies have shown that anti-nxp2 antibody (ab) is a major msa in juvenile dermatomyositis (jdm). |
2012-05-31 |
2023-08-12 |
Not clear |
| Nobuaki Ikeda, Kazuo Takahashi, Yukie Yamaguchi, Mai Inasaka, Masataka Kuwana, Zenro Ikezaw. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. The Journal of dermatology. vol 38. issue 10. 2012-01-20. PMID:21883412. |
new autoantibodies, anti-clinically amyopathic dermatomyositis 140 (anti-cadm-140) antibody (ab) and anti-155/140 ab, as well as anti-aminoacyl-trna synthetase (anti-ars) ab and anti-mi-2 ab, have been discovered and their utility indicated. |
2012-01-20 |
2023-08-12 |
Not clear |
| Yutaka Kuwatsuka, Fumihide Ogawa, Yohei Iwata, Kazuhiro Komura, Eiji Muroi, Toshihide Hara, Motoi Takenaka, Kazuhiro Shimizu, Minoru Hasegawa, Manabu Fujimoto, Shinichi Sat. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis. Autoimmunity. vol 42. issue 2. 2009-02-19. PMID:19021012. |
furthermore, decreased levels of igg anti-hdac-3 ab were specific to ssc, since igg anti-hdac-3 ab levels in patients with dermatomyositis (dm) and those with systemic lupus erythematosus (sle) were similar and slightly increased relative to normal controls, respectively. |
2009-02-19 |
2023-08-12 |
mouse |
| Masaki Nagai, Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sat. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma. The Journal of investigative dermatology. vol 122. issue 3. 2004-05-25. PMID:15086540. |
elisa using human purified cu/zn sod revealed that igg or igm anti-cu/zn sod ab was detected in the serum of 89% of localized scleroderma patients, especially 100% of patients with generalized morphea, the severest form of localized scleroderma, but was positive only in the serum of less than 15% of patients with other autoimmune disorders, including systemic sclerosis, systemic lupus erythematosus, dermatomyositis, and autoimmune bullous disorders. |
2004-05-25 |
2023-08-12 |
human |